Ensuring Quality, Safety, and Global Compliance Standards
The global medical device market is undergoing a seismic shift towards "Value-Based Healthcare." Suppliers are no longer just vendors; they are strategic partners in clinical outcomes. From respiratory catheters to high-potency API injections, the demand for precision and bioavailability is at an all-time high.
Compliance standards such as EU MDR, US FDA, and GMP/USP/BP requirements have become the baseline for entry. As a top-tier supplier, we ensure every product—from simple suction tubes to complex biological vaccines—meets rigorous multi-national safety protocols.
We are witnessing the convergence of pharmaceutical, nutritional, and medical device sectors. Our portfolio reflects this trend, offering both the delivery mechanisms (consumables) and the active therapeutic agents (APIs/Nutritional ingredients).
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices. Our premium products will bring back the health.
Established
Global Clients
Suppliers
Annual Sales (USD)
The resilience of the medical supply chain was tested globally in recent years. Serum Pharma has optimized the "China Advantage" not just through cost-efficiency, but through Industrial Cluster Efficiency. Our proximity to the world’s largest raw material manufacturing hubs allows us to mitigate lead-time risks and maintain a stable price-to-quality ratio that is unmatched in Western markets.
Our supply chain model integrates real-time inventory tracking with the "Just-In-Time" (JIT) delivery principle for medical consumables and pharmaceutical intermediates. By leveraging China's advanced logistics infrastructure, we ensure that critical products like Triple Lumen Foley Catheters and Enoxaparin Sodium Injection reach our international partners without clinical delay.
Focused on GMP/BP/USP compliance and mass-scale production of high-purity APIs like Florfenicol and Metronidazole. Integration of eco-friendly packaging for medical consumables.
Developing "Smart Consumables" and bio-fermented nutritional ingredients (PQQ/L-Theanine) with higher bioavailability through Co-Crystallization techniques.
AI-driven supply chain forecasting and custom formulation of vaccines and biological products tailored to specific regional epidemiological needs.
Serum Pharma continuously monitors the development of cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation product services.
Our Triple Lumen Foley Catheters and Suction tubes are engineered for durability and anti-clogging, essential for long-term patient stabilization in high-intensity clinical settings.
Livestock health is vital for food security. Our Florfenicol and Enrofloxacin injections provide rapid-effect treatment for ruminants and pets, supporting local agricultural sustainability.
With products like PQQ and Natural L-Theanine, we support the growing "Silver Economy" by providing high-quality nutritional support for cognitive health and anti-aging.
Exploring the shift from shark-based squalene to sustainable plant-derived alternatives in pharmaceutical formulations.
Analysis of why this API remains a critical molecule in modern medicine for treating inflammatory and autoimmune conditions.
The FDA's record 50-day approval of Eli Lilly's Foundayo™ (orforglipron) marks a new era in oral small-molecule GLP1 pathways.
